SGLT2 inhibitors slightly raise hemoglobin, an analysis of 85 trials confirms
A meta-analysis of 85 randomized trials, published Oct. 24, 2026, in JAMA, found that SGLT2 inhibitors raised hemoglobin by 0.60 g/dL more than control, a small increase whose clinical meaning is still…